The EU’s drug watchdog, the European Medicines Agency (EMA), said on Thursday that it would support a COVID-19 vaccine that targets the omicron variant. The EMA’s head of vaccine strategy, Marco Cavaleri, encouraged pharmaceutical companies to continue work on vaccines that target several variants but accepted that a shot tailored specifically for omicron could also be of use. “If an omicron monovalent vaccine can be put into clinical trials rapidly. I think we can only support that,” Cavaleri told journalists at a briefing. US company Pfizer and its German partner BioNTech are currently developing a newer version of their jab to target the omicron variant which has so far proven more evasive of vaccine protections. Nevertheless, the EMA official said the development of polyvalent vaccines would be “the most robust way forward.” Watch video 26:00 Covid-19 Special – How do the vaccines differ? Here are the latest major developments on coronavirus from around the world: Americas The United States Army said it will start discharging soldiers who refuse to take the COVID-19 vaccine. “Unvaccinated Soldiers present a risk to the force and jeopardize readiness,” said Secretary of the Army Christine Wormuth. “We will begin involuntary separation proceedings for Soldiers who… Read full this story
- GPs who prescribe homeopathy are more likely to go against medical guidelines, study suggests
- Press digest – September 24
- Merck & Co. (MRK) Q4 2016 Results - Earnings Call Transcript
- Did deforestation cause the Ebola outbreak?
- Case of tuberculosis confirmed at Brandeis High School
- Case of tuberculosis confirmed at Texas high school
- Uganda: Street Children
- Industrial Development Strategy through 2025, vision to 2035
- Social News 7/8
- East Africa: Comesa Partner States Upbeat About Digital Free Trade Area
COVID digest: EU medical watchdog open to omicron-specific vaccines have 269 words, post on www.dw.com at January 3, 2022. This is cached page on wBird. If you want remove this page, please contact us.